Systemic inflammation and dyslipidemia are associated with retinopathy in type 2 but not in type 1 diabetes

References

• International Diabetes Federation (IDF). IDF Diabetes Atlas. 9th edition. Belgium: International Diabetes Federation; 2019.
   Google Scholar
• Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e1234.
   PubMed Web of Science ®Google Scholar
• Stewart MW. Treatment of diabetic retinopathy: recent advances and unresolved challenges. World J Diabetes. 2016;7(16):333–341.
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European society of retina specialists (EURETINA). Ophthalmologica. 2017;237(4):185–222.
   PubMed Web of Science ®Google Scholar
• Wong TY, Sun J, Kawasaki R, et al. Guidelines on diabetic eye care: The International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125(10):1608–1622.
   PubMed Web of Science ®Google Scholar
• Shaya FT, Aljawadi M. Diabetic retinopathy. Clin Ophthalmol. 2007;1(3):259–265.
   PubMedGoogle Scholar
• Jeng CJ, Hsieh YT, Yang CM, et al. Diabetic retinopathy in patients with diabetic nephropathy: development and progression. PLOS One. 2016;11(8):e0161897
   PubMed Web of Science ®Google Scholar
• Wolf G, Müller N, Mandecka A, et al. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus. CN. 2007;68(08):81–86.
   Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diab. 2011;29(3):116–122.
   Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(suppl. 1):S13–S22.
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza'ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863.
   PubMed Web of Science ®Google Scholar
• Pietzner M, Kaul A, Henning AK, et al. Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals. BMC Med. 2017;15(1):210
   PubMed Web of Science ®Google Scholar
• Van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Obesity associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med. 2013;71(4):174–187.
   PubMed Web of Science ®Google Scholar
• León-Pedroza JI, González-Tapia LA, del Olmo-Gil E, et al. Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice. Cir Cir. 2015;83(6):543–551.
   PubMed Web of Science ®Google Scholar
• Kitamura H, Kimura S, Shimamoto Y, et al. Ubiquitin-specific protease 2–69 in macrophages potentially modulates metainflammation. FASEB J. 2013;27(12):4940–4953.
   PubMed Web of Science ®Google Scholar
• Rübsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. IJMS. 2018;19(4):942.
   Web of Science ®Google Scholar
• Vujosevic S, Simo R. Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest Ophthalmol Vis Sci. 2017;58(6):BIO68–BIO75.
   PubMed Web of Science ®Google Scholar
• Lammert A, Hasenberg T, Kraupner C, et al. Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery. Obesity (Silver Spring). 2012;20(11):2262–2267.
   PubMed Web of Science ®Google Scholar
• Song SJ. Obesity and diabetic retinopathy: new perspectives. JAMA Ophthalmol. 2016;134(3):258
   PubMed Web of Science ®Google Scholar
• Zhu W, Wu Y, Meng YF, et al. Association of obesity and risk of diabetic retinopathy in diabetes patients: A meta-analysis of prospective cohort studies. Medicine (Baltimore). 2018;97(32):e11807
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622–627.
   PubMed Web of Science ®Google Scholar
• Aldington SJ, Kohner EM, Meuer S, et al. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia. 1995;38(4):437–444.
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FII, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682.
   PubMed Web of Science ®Google Scholar
• Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. 3rd ed. New York: Freeman WH and Co; 1995.
   Google Scholar
• TIBCO Software Inc. 2018. TIBCO Statistica™ Software, Version 13.5. Palo Alto, USA.
   Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859–1868.
   PubMed Web of Science ®Google Scholar
• Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592–596.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus (UKPDS 69). Arch Ophthalmol. 2004;122:1631–1640.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Estacio RO, Mehler PS, et al. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Rev Nephrol. 2007;3(8):428–438.
   Web of Science ®Google Scholar
• Zheng Y, Lamoureux EL, Lavanya R, et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian Eye Study. Ophthalmology. 2012;119(10):2119–2124.
   PubMed Web of Science ®Google Scholar
• Chen H, Zheng Z, Huang Y, et al. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLOS One. 2012;7(5):e36718.
   PubMed Web of Science ®Google Scholar
• Kramer CK, Retnakaran R. Concordance of retinopathy and nephropathy over time in type 1 diabetes: an analysis of data from the diabetes control and complications trial. Diabet Med. 2013;30(11):1333–1341.
   PubMed Web of Science ®Google Scholar
• Chen YH, Chen HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care. 2012;35(4):803–808.
   PubMed Web of Science ®Google Scholar
• Chapter 1: definition and classification of CKD. Kidney Int Suppl. (2011) 2013;3:19–62.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Obesity: situation and trends. Geneva, Switzerland: WHO 2017. Available from: http://www.who.int/gho/ncd/risk_factors/obesity_text/en/
   Google Scholar
• Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metab Clin Exp. 2019;92:6–10.
   PubMed Web of Science ®Google Scholar
• Csige I, Ujvárosy D, Szabó Z, et al. The impact of obesity on the cardiovascular system. J Diabetes Res. 2018;2018:3407306
   PubMed Web of Science ®Google Scholar
• Muni RH, Kohly RP, Lee EQ, et al. Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. JAMA Ophthalmol. 2013;131(4):514–521.
   PubMed Web of Science ®Google Scholar
• Semeraro F, Cancarini A, dell'Omo R, et al. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Toma C. Diabetic retinopathy: an inflammatory disease. Ann Eye Sci. 2018;3:52–52.
   Google Scholar
• Sasongko MB, Wong TY, Jenkins AJ, et al. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med. 2015;32(5):686–691.
   PubMed Web of Science ®Google Scholar
• Sacks FM, Hermans MP, Fioretto P, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 2014;129(9):999–1008.
   PubMed Web of Science ®Google Scholar
• Vivekanandan S. Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian J Ophthalmol. 2012;60(6):579–580.
   PubMed Web of Science ®Google Scholar
• Jacobson TA, Ito MK, Maki KC, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report. J Clin Lipidol. 2015;9(2):129–169.
   PubMed Web of Science ®Google Scholar